GL1X · GenesisL1 explorer

MolNFT v1 · #62582 · protein

Golgi alpha-mannosidase II in complex with 5-substituted swainsonine analog: (5S)-5-[2'-(4-tert-BUTYLPHENYL)ETHYL]-swainsonine

3EJS · Alpha-mannosidase 2: “Golgi alpha-mannosidase II in complex with 5-substituted swainsonine analog…”. X-ray diffraction, 3 ligands (HN5, NAG, ZN), 14 pockets (best druggability 0.81). MolNFT v1 #62582 on GenesisL1: 3D structure…

PDB
3EJS
Type
protein
Length
1,016 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-mannosidase 2
EC
3.2.1.114
UniProt
Q24451
Ligands
HN5, NAG, ZN
Pockets
14 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-mannosidase 2 (EC 3.2.1.114)protein101624% helix, 30% strandQ24451

Ligands and binding sites

  • HN5 · (1S,2R,5S,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • ZN · Zinc ion · metal · chains A
  • MRD · (4R)-2-methylpentane-2,4-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11480.810.9733empty
22000.780.9329empty
36450.730.8095empty
42760.640.8131empty
52470.520.7633HN5

Modifications

Observed in the structure: 5 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 3EJS · Golgi alpha-Mannosidase II in complex with 5-substituted swainsonine analog… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.